查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1867162

胃肠道器械市场按产品类型、应用、最终用户和技术划分－2025-2032年全球预测

Gastrointestinal Devices Market by Product Type, Application, End User, Technology - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，胃肠道设备市场规模将达到 149.1 亿美元，复合年增长率为 7.90%。

关键市场统计数据
基准年 2024 81.1亿美元
预计年份：2025年 87.6亿美元
预测年份 2032 149.1亿美元
复合年增长率 (%) 7.90%

本文简要介绍了临床驱动因素、技术加速发展和相关人员的优先事项将如何塑造胃肠道器材创新的未来。

胃肠道医疗器材领域正处于临床需求、技术快速发展和医疗服务模式不断演变的交会点。近年来，诊断影像、治疗性内视镜和止血技术取得了全面进步，这些进步的结合使得临床决策能够更早做出，并减少了侵入性干预。这些趋势的驱动因素包括：对微创手术的需求日益增长、对门诊和日间护理的重视，以及对高解析度视觉化以识别细微黏膜病变的需求。为此，医疗设备开发商和临床团队正在尝试开发整合卓越光学性能、精密辅助器具和软体驱动工作流程的平台，以缩短手术时间并提高治疗精度。

深入分析临床实务、技术和商业模式的变革性转变如何重塑手术地点、设备采用和竞争动态。

胃肠道器械领域正处于变革的关键时期，临床路径和商业模式正在转变。高解析度成像和小型化平台使得病变早期检测成为可能，并影响诊断演算法和治疗策略。同时，光学技术、机器人技术和软体分析的融合正在催生新型混合平台，这些平台兼具诊断准确性和精准介入能力，并将手术从住院转移到门诊和日间手术中心。

对2025年美国关税对胃肠道器械製造商供应链、筹资策略和商业计划的影响进行全面检验

2025年美国关税政策对全球胃肠器械製造商的供应链造成了不利影响，从多方面衝击了零件采购、生产策略和定价策略。拥有垂直整合供应链和国内生产能力的製造商受到的影响相对较小，而那些严重依赖进口零件和成品的製造商则不然。因此，采购部门必须重新评估供应商多元化和近岸外包的机会，以降低相关关税带来的风险。

全面的细分洞察，阐释产品类型、临床应用、最终用户和技术选择如何驱动差异化应用和市场定位。

细分市场分析表明，在整个胃肠病学领域，产品多样性和功能专业化是商业化策略和临床应用路径的核心。依产品类型分析，主要器械类别包括胶囊内视镜系统、内视镜成像系统、内视镜治疗器械和止血器械。在内视镜成像领域，高清内视镜、超细内视镜和影像内视镜等细分子类别分别针对不同的临床应用场景：提高黏膜可视性、进入解剖结构狭窄的腔体以及整合数位化工作流程。内视镜治疗器械也呈现类似的分类，扩张球囊用于结构性介入治疗，息肉切除器械用于切除病变，支架用于维持管腔通畅。这些器械的选择取决于病变特征和手术目标。止血装置进一步细分为止血夹、止血粉和热凝固装置，选择依据出血病因、可近性和临床医师的偏好。

策略性区域洞察：详细阐述美洲、欧洲、中东和非洲以及亚太地区之间的差异将如何影响医疗器材的采用、证据要求和商业性策略。

区域趋势将对胃肠道器材的临床功能优先顺序、报销关键因素和上市策略产生重大影响。在美洲，医疗服务模式的转变正推动着向门诊治疗的转型、医疗系统的整合，以及对既能提高诊疗效率又能保持强有力临床证据支持的器械的需求。该地区普遍采用与流程效率和集中采购机制相契合的技术，但对可靠的上市后数据和可互操作系统的需求也同样迫切。

关键的企业策略和竞争行动揭示了平台领导者、敏捷创新者和製造合作伙伴如何塑造市场走向。

胃肠道器械领域由成熟的平台供应商、专业创新者和垂直整合的製造商组成。主要企业通常会投资于全面的临床试验、严格的上市后监测以及与医疗系统的合作，以证明其产品的价值。这些企业利用模组化平台实现逐步升级，从而推动长期用户群的获利，并透过耗材和配件获得持续收入。

为製造商和供应商提供切实可行的、优先排序的建议，以加速临床应用、增强韧性并实现商业性差异化。

产业领导者应优先采取一系列切实可行的措施，以在胃肠道器械领域实现临床、营运和商业性价值。首先，将产品开发与可衡量的临床结果和营运效率提升相结合，使采购委员会能够轻鬆量化其价值。投资于产生真实世界证据，以证明其能够缩短手术时间、降低併发症发生率并提高诊断准确性，从而加快支付方和医疗服务提供者的接受度。其次，实现供应链多元化并开发模组化设计，以便在不影响临床疗效的前提下进行组件替换，从而降低政策主导的成本衝击风险，并支持灵活生产。

对三角测量调查方法的清晰解释，该方法结合了初步临床发现、二次文献检验和基于情境的供应链分析。

本执行摘要摘要的研究综合采用了一种三角测量法，结合了主要相关利益者的对话、二手证据综合以及基于情境的供应链分析。一手资料包括对临床意见领袖、采购人员和产品开发负责人进行的结构化访谈，以收集关于可用性、临床优先事项和商业性限制的实际观点。第二手资料则利用了同行评审的临床文献、监管指导文件和已发布的程序最佳实践，以检验临床性能声明并确保其符合当前的护理标准。

简洁扼要的结论摘要了技术创新、供应链韧性和证据生成如何决定永续应用和价值创造。

总之，胃肠器材产业的特点是技术快速进步、医疗服务模式不断转变，以及日益复杂的商业环境，该环境重视实证创新和营运韧性。高清影像、机器人技术和新型止血方法正在重新定义诊断和治疗的可能性，而不断扩大的门诊服务和区域差异则要求制定量身定制的商业策略。 2025 年关税凸显了供应链弹性和成本模型（考虑总到岸成本而非仅考虑组件成本）的策略重要性。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 开发配备人工智慧的胶囊内视镜系统用于消化系统疾病的早期检测
  • 扩大微创机器人辅助腔内手术在胃肠道治疗的应用
  • 将即时远端监测感测器整合到智慧胃肠道支架和导管中
  • 扩大可生物降解聚合物基食道和结肠支架的应用，以减少併发症
  • 用于靶向胃肠道治疗的自动化精准药物输送系统的进展
  • 扩大一次性内视镜的使用范围，以提高手术安全性并减少交叉感染

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 消化系统设备市场（依产品类型划分）

  • 胶囊内视镜系统
  • 内视镜成像系统
    • 高清内视镜
    • 超细内视镜
    • 影像内视镜
  • 内视镜治疗设备
    • 膨胀气球
    • 息肉切除装置
    • 支架
  • 止血装置
    • 夹子
    • 止血粉
    • 热凝固设备

第九章 按应用分類的消化系统设备市场

  • 出血控制
    • 机械止血
    • 喷雾型止血剂
    • 热凝固
  • 诊断影像
    • 病灶可视化
    • 运动功能评估
  • 息肉检测
  • 狭窄扩张

第十章 依最终用户分類的消化系统设备市场

  • 门诊手术中心
  • 诊断中心
  • 医院
  • 专科诊所

第十一章 消化系统设备市场（依技术划分）

  • 胶囊内视镜
  • 光学内视镜
    • 软式内视镜
    • 硬式内视镜
  • 机器人内视镜
  • 超音波超音波
    • 线性超音波内视镜
    • 径向超音波超音波

第十二章：按地区分類的胃肠道器械市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 消化系统器材市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国胃肠道器材市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Olympus Corporation
    • FUJIFILM Holdings Corporation
    • HOYA CORPORATION
    • Medtronic plc
    • Boston Scientific Corporation
    • KARL STORZ SE & Co. KG
    • Becton, Dickinson and Company
    • Cook Medical LLC
    • Erbe Elektromedizin GmbH
    • CONMED Corporation
Product Code: MRR-7949F05839D3

The Gastrointestinal Devices Market is projected to grow by USD 14.91 billion at a CAGR of 7.90% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 8.11 billion
Estimated Year [2025] USD 8.76 billion
Forecast Year [2032] USD 14.91 billion
CAGR (%) 7.90%

Concise introduction framing clinical drivers, technological acceleration, and stakeholder priorities shaping the future of gastrointestinal device innovation

The gastrointestinal devices landscape sits at the confluence of clinical necessity, technological acceleration, and evolving care delivery models. Recent years have seen end-to-end advances in diagnostic imaging, therapeutic endoscopy, and hemostasis that together shift clinical decision making earlier and reduce invasive interventions. These trends are driven by rising demand for minimally invasive procedures, a growing emphasis on outpatient and ambulatory care, and the necessity for higher-resolution visualization to identify subtle mucosal lesions. In turn, device developers and clinical teams are experimenting with integrated platforms that couple superior optics, refined accessory tools, and software-enabled workflows to shorten procedure time and enhance therapeutic precision.

Against this backdrop, stakeholders from hospital systems to specialty clinics are prioritizing devices that demonstrably improve throughput, lower complications, and enable remote or hybrid care pathways. Policymakers and payers are also influencing adoption through updated reimbursement frameworks that favor value-based outcomes. Moreover, device manufacturers face an increasingly complex regulatory environment in which evidence generation and post-market surveillance carry heightened importance. Taken together, these dynamics set the stage for a highly competitive innovation cycle, where clinical efficacy, workflow compatibility, and economic value determine which technologies achieve scale and which remain niche solutions.

In-depth analysis of the transformative clinical, technological, and commercial shifts reshaping procedure locations, device adoption, and competitive dynamics

The gastrointestinal device landscape is undergoing transformative shifts that are altering clinical pathways and commercial models. Technologically, higher-definition imaging and miniaturized platforms are enabling lesion detection at earlier stages, thereby influencing diagnostic algorithms and therapeutic intent. Concurrently, the convergence of optics, robotics, and software analytics is producing new hybrid platforms that couple diagnostic clarity with precise intervention capabilities, shifting procedural volumes from inpatient to ambulatory settings.

Operationally, the migration toward outpatient and ambulatory surgical centers is reshaping purchasing priorities; providers prioritize disposables that reduce turnover time and capital equipment that delivers robust utilization metrics. Meanwhile, digital integration, including enhanced image management and procedural analytics, is enabling performance benchmarking and remote proctoring, which accelerate clinician adoption curves. Regulatory and reimbursement practice updates are further incentivizing devices that show clear outcomes and cost-efficiencies. In market terms, smaller fast-moving innovators are challenging incumbent suppliers by targeting unmet clinical niches with focused, evidence-backed solutions. As a result, the competitive landscape favors agility, clinical trial rigor, and scalable manufacturing strategies that can support rapid market entry and iterative device improvements.

Comprehensive examination of how the 2025 U.S. tariffs reshaped supply chains, sourcing strategies, and commercial planning across gastrointestinal device makers

The tariff environment introduced by the United States in 2025 has created headwinds across global supply chains for gastrointestinal device manufacturers, with layered effects on component sourcing, manufacturing strategies, and pricing approaches. Manufacturers with vertically integrated supply chains or domestic production capacity experienced relative insulation compared with those that rely heavily on imported subassemblies or finished devices. As a consequence, procurement teams have had to reassess supplier diversity and nearshoring opportunities to mitigate exposure to applied duties.

In practice, the cumulative tariff impact extended beyond direct cost increases, influencing contractual negotiations and lead-time planning. OEMs and contract manufacturers began to restructure agreements to shift risk or incorporate tariff clauses, while strategic buyers accelerated dual-sourcing strategies to preserve continuity. Furthermore, some firms responded by qualifying alternative suppliers from tariff-favored regions or by investing in modular design changes that allowed substitution of affected components without compromising clinical performance. Importantly, this period strengthened the business case for greater supply chain transparency and scenario planning, with commercial teams increasingly modeling total landed cost rather than unit price alone. Taken together, the tariff developments underscored the necessity for resilience-oriented procurement, flexible manufacturing footprints, and commercial strategies that anticipate policy volatility without undermining clinical adoption timelines.

Holistic segmentation insights explaining how product categories, clinical applications, end users, and technology choices drive differentiated adoption and positioning

Segmentation insight reveals that product diversity and functional specialization are central to commercialization strategies and clinical adoption pathways across the gastrointestinal space. When analyzed by product type, key device categories include capsule endoscopy systems, endoscopic imaging systems, endotherapy devices, and hemostasis devices. Within endoscopic imaging, the differentiated subcategories of high-definition endoscopes, ultrathin endoscopes, and video endoscopes each address distinct clinical use cases: enhanced mucosal visualization, access to anatomically narrow lumens, and integrated digital workflows respectively. Endotherapy devices display similar stratification, where dilation balloons serve structural interventions, polypectomy devices address lesion resection, and stents support luminal patency; the choice among these tools often depends on lesion characteristics and procedural intent. Hemostasis devices further stratify into clips, hemostatic powders, and thermal coagulation devices, each selected based on bleeding etiology, accessibility, and clinician preference.

From an application standpoint, devices are deployed across bleeding management, diagnostic imaging, polyp detection, and stricture dilation. Bleeding management itself breaks down into mechanical hemostasis, sprayable hemostats, and thermal coagulation modalities, with selection influenced by bleed source and procedural context. Diagnostic imaging applications include lesion visualization and motility assessment, reflecting a dual focus on structural and functional diagnostics. In terms of end users, the buyer landscape spans ambulatory surgical centers, diagnostic centers, hospitals, and specialty clinics, each with different purchasing cycles, capital constraints, and utilization expectations. Finally, the technology axis differentiates capsule endoscopy, optical endoscopy, robotic endoscopy, and ultrasound endoscopy. Optical systems further bifurcate into flexible and rigid endoscopes, while ultrasound endoscopy differentiates into linear and radial ultrasound endoscopes, reflecting divergent imaging geometries and clinical indications. Integrating these segmentation perspectives clarifies how product development, commercial positioning, and evidence generation must align to meet the heterogeneous needs of clinicians and care settings.

Strategic regional insights detailing how Americas, Europe, Middle East & Africa, and Asia-Pacific differences shape device adoption, evidence needs, and commercial approaches

Regional dynamics materially influence prioritization of clinical features, reimbursement levers, and go-to-market strategies for gastrointestinal devices. In the Americas, healthcare delivery trends emphasize outpatient shift, consolidation of health systems, and an appetite for devices that improve throughput while maintaining strong clinical evidence. This region commonly demonstrates rapid uptake of technologies that align with procedural efficiency and centralized purchasing mechanisms, but also expects robust post-market data and interoperable systems.

In Europe, Middle East & Africa, heterogeneity in regulatory frameworks and reimbursement pathways means market entry strategies must be highly localized. Western European markets often demand rigorous clinical validation and demonstrate steady adoption for high-definition imaging and integrated platforms, whereas some emerging markets in the region prioritize cost-effective disposables and modular solutions. In the Middle East and Africa, infrastructure constraints and import logistics drive preference for durable equipment, simplified maintenance, and flexible training support. Across Asia-Pacific, diverse healthcare delivery models range from highly advanced tertiary care centers that adopt leading-edge endoscopic robotics to rapidly growing ambulatory networks in urban centers seeking commercially viable, scalable devices. Procurement strategies here frequently balance accelerated adoption in metropolitan hubs against price sensitivity in broader geographies. Recognizing these regional distinctions enables manufacturers to tailor clinical evidence packages, service models, and commercial approaches in ways that respect local decision drivers and accelerate sustainable adoption.

Key corporate strategies and competitive behaviors revealing how platform leaders, agile innovators, and manufacturing partners shape market trajectories

Competitive dynamics in the gastrointestinal devices arena are defined by a mix of established platform providers, targeted innovators, and vertically integrated manufacturers. Leading firms typically invest in comprehensive clinical programs, rigorous post-market surveillance, and partnerships with healthcare systems to demonstrate value. These companies often leverage modular platforms that allow incremental upgrades, facilitating long-term installed-base monetization and recurring revenue from consumables and accessories.

At the same time, smaller specialist firms and start-ups drive innovation in narrow clinical niches by rapidly iterating on design and leveraging focused clinical trials to capture early adopters. Their agility enables experimentation with alternative business models, such as service-based offerings or bundled procedural pricing, which can accelerate penetration in ambulatory and diagnostic center settings. Contract manufacturing organizations and component specialists have also become strategic partners; they enable cost-effective scaling and help OEMs navigate tariff-induced supply chain shifts by offering distributed manufacturing footprints. Across this ecosystem, companies that align rigorous clinical evidence with clear economic arguments and strong training and service models tend to outperform peers. Strategic alliances, co-development arrangements, and targeted acquisitions remain common approaches to augment technology portfolios and accelerate access to complementary channels and geographies.

Practical and prioritized recommendations for manufacturers and providers to enhance adoption, resilience, and commercial differentiation across clinical settings

Industry leaders should prioritize a set of pragmatic actions to capture clinical, operational, and commercial value across the gastrointestinal device landscape. First, align product development with measurable clinical outcomes and workflow efficiency gains so that procurement committees can readily quantify value. Investing in real-world evidence generation that demonstrates reduced procedure time, lower complication rates, or improved diagnostic yields will accelerate payer and institutional acceptance. Second, diversify supply chains and develop modular designs that allow component substitution without clinical compromise; this will reduce exposure to policy-driven cost shocks and support flexible manufacturing.

Third, tailor go-to-market approaches by end-user segment and region, recognizing that hospitals, ambulatory surgical centers, diagnostic centers, and specialty clinics have different capital cycles and utilization expectations. Fourth, build robust training and service programs that reduce learning curves and ensure consistent clinical outcomes; remote proctoring and digital training modules can be cost-effective ways to scale education globally. Fifth, explore innovative commercial models such as outcome-linked pricing, refurbished equipment programs, and consumable subscription models to align incentives with volume and value. Finally, pursue targeted partnerships to complement internal capabilities-whether for imaging software, robotics, or advanced materials-so that product roadmaps can accelerate while mitigating integration risk. Collectively, these actions can improve adoption velocity and create defensible value propositions in a competitive marketplace.

Transparent description of the triangulated research methodology combining primary clinical insights, secondary literature validation, and scenario-based supply chain analysis

The research synthesis underpinning this executive summary employed a triangulated methodology that combined primary stakeholder engagements with secondary evidence synthesis and scenario-based supply chain analysis. Primary inputs included structured interviews with clinical opinion leaders, procurement executives, and product development leaders to capture frontline perspectives on usability, clinical priorities, and commercial constraints. Secondary sources comprised peer-reviewed clinical literature, regulatory guidance documents, and published procedural best practices to validate clinical performance claims and to ensure alignment with current standards of care.

To understand operational resilience, scenario modeling was conducted to evaluate supply chain disruption vectors and tariff impacts, assessing mitigation options such as supplier diversification and nearshoring. Data validation steps included cross-referencing clinician-reported preferences with device utilization trends and post-market safety bulletins. The methodological approach prioritized transparency in assumptions, documented data provenance, and iterative validation with domain experts to minimize bias. Where evidence gaps were identified, recommended data collection pathways are included to support future iterations of the analysis, such as focused clinical registries or payer claims modeling to better quantify downstream economic outcomes.

Concise conclusion summarizing how technological innovation, supply chain resilience, and evidence generation determine sustainable adoption and value creation

In conclusion, the gastrointestinal devices domain is characterized by rapid technological progress, shifting care delivery paradigms, and an increasingly complex commercial environment that rewards evidence-driven innovation and operational resilience. High-definition imaging, robotics, and novel hemostasis modalities are redefining diagnostic and therapeutic possibilities, while outpatient care growth and regional variations necessitate tailored commercial strategies. The 2025 tariffs highlighted the strategic importance of supply chain flexibility and cost modeling that account for total landed cost rather than component price alone.

Looking ahead, organizations that pair rigorous clinical validation with adaptable manufacturing and pragmatic go-to-market models will be best positioned to scale. Equally important is the ability to provide comprehensive training and service to ensure consistent outcomes across diverse clinical settings. Ultimately, success will hinge on aligning product performance with measurable clinical benefit and economic value, enabling stakeholders to adopt innovations that improve patient care while sustaining long-term commercial viability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Development of AI-powered capsule endoscopy systems for early gastrointestinal disease detection
  • 5.2. Expansion of minimally invasive robotic-assisted endoluminal procedures in GI treatments
  • 5.3. Integration of real-time remote monitoring sensors in smart gastrointestinal stents and catheters
  • 5.4. Emerging adoption of biodegradable polymer-based esophageal and colonic stents to reduce complications
  • 5.5. Advances in automated precision drug delivery systems for targeted gastrointestinal therapy
  • 5.6. Growth of disposable single-use endoscopes to enhance procedure safety and reduce cross-contamination

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastrointestinal Devices Market, by Product Type

  • 8.1. Capsule Endoscopy Systems
  • 8.2. Endoscopic Imaging Systems
    • 8.2.1. High Definition Endoscopes
    • 8.2.2. Ultrathin Endoscopes
    • 8.2.3. Video Endoscopes
  • 8.3. Endotherapy Devices
    • 8.3.1. Dilation Balloons
    • 8.3.2. Polypectomy Devices
    • 8.3.3. Stents
  • 8.4. Hemostasis Devices
    • 8.4.1. Clips
    • 8.4.2. Hemostatic Powders
    • 8.4.3. Thermal Coagulation Devices

9. Gastrointestinal Devices Market, by Application

  • 9.1. Bleeding Management
    • 9.1.1. Mechanical Hemostasis
    • 9.1.2. Sprayable Hemostats
    • 9.1.3. Thermal Coagulation
  • 9.2. Diagnostic Imaging
    • 9.2.1. Lesion Visualization
    • 9.2.2. Motility Assessment
  • 9.3. Polyp Detection
  • 9.4. Stricture Dilation

10. Gastrointestinal Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Diagnostic Centers
  • 10.3. Hospitals
  • 10.4. Specialty Clinics

11. Gastrointestinal Devices Market, by Technology

  • 11.1. Capsule Endoscopy
  • 11.2. Optical Endoscopy
    • 11.2.1. Flexible Endoscopes
    • 11.2.2. Rigid Endoscopes
  • 11.3. Robotic Endoscopy
  • 11.4. Ultrasound Endoscopy
    • 11.4.1. Linear Ultrasound Endoscopes
    • 11.4.2. Radial Ultrasound Endoscopes

12. Gastrointestinal Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Gastrointestinal Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Gastrointestinal Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Olympus Corporation
    • 15.3.2. FUJIFILM Holdings Corporation
    • 15.3.3. HOYA CORPORATION
    • 15.3.4. Medtronic plc
    • 15.3.5. Boston Scientific Corporation
    • 15.3.6. KARL STORZ SE & Co. KG
    • 15.3.7. Becton, Dickinson and Company
    • 15.3.8. Cook Medical LLC
    • 15.3.9. Erbe Elektromedizin GmbH
    • 15.3.10. CONMED Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GASTROINTESTINAL DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. GASTROINTESTINAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GASTROINTESTINAL DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HIGH DEFINITION ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HIGH DEFINITION ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HIGH DEFINITION ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HIGH DEFINITION ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HIGH DEFINITION ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HIGH DEFINITION ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRATHIN ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRATHIN ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRATHIN ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRATHIN ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRATHIN ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRATHIN ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY VIDEO ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY VIDEO ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY VIDEO ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY VIDEO ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY VIDEO ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY VIDEO ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DILATION BALLOONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DILATION BALLOONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DILATION BALLOONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DILATION BALLOONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DILATION BALLOONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DILATION BALLOONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYPECTOMY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYPECTOMY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYPECTOMY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYPECTOMY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYPECTOMY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYPECTOMY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CLIPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CLIPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CLIPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CLIPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CLIPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CLIPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTATIC POWDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTATIC POWDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTATIC POWDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTATIC POWDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTATIC POWDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTATIC POWDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MECHANICAL HEMOSTASIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MECHANICAL HEMOSTASIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MECHANICAL HEMOSTASIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MECHANICAL HEMOSTASIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MECHANICAL HEMOSTASIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MECHANICAL HEMOSTASIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPRAYABLE HEMOSTATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPRAYABLE HEMOSTATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPRAYABLE HEMOSTATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPRAYABLE HEMOSTATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPRAYABLE HEMOSTATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPRAYABLE HEMOSTATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LESION VISUALIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LESION VISUALIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LESION VISUALIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LESION VISUALIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LESION VISUALIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LESION VISUALIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MOTILITY ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MOTILITY ASSESSMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MOTILITY ASSESSMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MOTILITY ASSESSMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MOTILITY ASSESSMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MOTILITY ASSESSMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYP DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYP DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYP DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYP DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYP DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYP DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STRICTURE DILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STRICTURE DILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STRICTURE DILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STRICTURE DILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STRICTURE DILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STRICTURE DILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ROBOTIC ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ROBOTIC ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ROBOTIC ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ROBOTIC ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ROBOTIC ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ROBOTIC ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LINEAR ULTRASOUND ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LINEAR ULTRASOUND ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LINEAR ULTRASOUND ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LINEAR ULTRASOUND ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LINEAR ULTRASOUND ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LINEAR ULTRASOUND ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RADIAL ULTRASOUND ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RADIAL ULTRASOUND ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RADIAL ULTRASOUND ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RADIAL ULTRASOUND ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RADIAL ULTRASOUND ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RADIAL ULTRASOUND ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 276. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 291. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 294. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 295. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2024 (USD MILLION)
  • TABLE 296. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC